Bafna Pharmaceuticals Limited

This company manufactures pharmaceutical products and has expanded to international markets.

1995 | Chennai, Tamil Nadu (India) | Active
Last Updated:

Bafna Pharmaceuticals Profile

Key Indicators

  • Authorised Capital ₹ 40.00 Cr
  • Paid Up Capital ₹ 23.66 Cr
  • Company Age 29 Year, 11 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 62.35 Cr
  • Satisfied Charges ₹ 159.66 Cr
  • Revenue Growth 31.50%
  • Profit Growth -35.19%
  • Ebitda -29.30%
  • Net Worth 10.05%
  • Total Assets 13.97%

About Bafna Pharmaceuticals

Bafna Pharmaceuticals Limited (BPL) is a leading Public Limited Indian Non-Government Company incorporated in India on 28 March 1995 and has a history of 29 years and 11 months. Its registered office is in Chennai, Tamil Nadu, India.

It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 532989 and on the National Stock Exchange(NSE) under BAFNAPH.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 40.00 Cr and a paid-up capital of Rs 23.66 Cr.

The company currently has active open charges totaling ₹62.35 Cr. The company has closed loans amounting to ₹159.66 Cr, as per Ministry of Corporate Affairs (MCA) records.

The Key Managerial Personnel (KMP) at Bafna Pharmaceuticals Limited India are Mahaveer Bafna as Ceo, Ashok Mohanachandran as Company Secretary, Bafna Chand as Ceo, and One other members. Krishna Yeachuri, Shanmugam Hemalatha, Sundaresan Palamadai, and Four other members serve as directors at the Company.

Company Details

  • Location

    Chennai, Tamil Nadu, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

    bafnapharma.com

  • Social Media
    -

Corporate Identity Details

  • CIN/LLPIN

    L24294TN1995PLC030698

  • Company No.

    030698

  • Stock Symbol

    BSE : 532989 NSE : BAFNAPH

  • Company Classification

    Public Limited Indian Non-Government Company

  • Incorporation Date

    28 Mar 1995

  • Date of AGM

    25 Sep 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Listed

  • ROC Code

    Roc Chennai

Industry

Pharma

Who are the key members and board of directors at Bafna Pharmaceuticals?

Executive Team (4)

NameDesignationAppointment DateStatus
Mahaveer Bafna Country flag representing In CEOCurrent
Ashok Mohanachandran Company Secretary27-Jun-2024Current
Bafna Chand CEO10-Sep-2020Current
Melagiri Sridhar Country flag representing In CFO27-May-2017Current

Board Members (7)

NameDesignationAppointment DateStatus
Krishna Yeachuri Country flag representing In Director 26-Jun-2023Current
Shanmugam Hemalatha Country flag representing In Whole-Time Director 10-Sep-2020Current
Sundaresan Palamadai Country flag representing In Director 25-Jun-2020Current
Akila Raju Country flag representing In Director 10-Sep-2020Current
Vinayak Dendukuri Country flag representing In Whole-Time Director 26-Jun-2023Current
Ravichandran Chitra Country flag representing In Director 12-Nov-2020Current

Financial Performance of Bafna Pharmaceuticals.

Bafna Pharmaceuticals Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 31.5% increase. The company also saw a substantial fall in profitability, with a 35.19% decrease in profit. The company's net worth Soared by an impressive increase of 10.05%.

Bafna Pharmaceuticals revenue growth over time
Bafna Pharmaceuticals profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
31.50%
Revenue from Operations
32.18%
Total Assets
13.97%
Profit or Loss
-35.19%
Net Worth
10.05%
EBITDA
-29.30%

What is the Ownership and Shareholding Structure of Bafna Pharmaceuticals?

In 2024, Bafna Pharmaceuticals had a promoter holding of 88.29% and a public holding of 11.70%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹62.35 Cr

Satisfied Charges

₹159.66 Cr

Charges Breakdown by Lending Institutions

  • Others : 62.35 Cr

Latest Charge Details

DateLenderAmountStatus
11 Sep 2024Others₹6.35 CrOpen
21 Feb 2024Others₹12.00 CrOpen
30 Nov 2023Others₹12.00 CrOpen
05 Jun 2023Others₹2.00 CrOpen
27 Oct 2021Others₹5.00 CrOpen

How Many Employees Work at Bafna Pharmaceuticals?

Bafna Pharmaceuticals has a workforce of 379 employees as of Feb 28, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee growth trends for Bafna Pharmaceuticals Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Bafna Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bafna Pharmaceuticals's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Bafna Pharmaceuticals

Recent activity within the organization

  • Charges

    A charge with Others of Rs. 6.35 Cr registered on 11 Sep 2024 with Charge ID 100983429 was modified on 03 Oct 2024.

  • Annual General Meeting

    Bafna Pharmaceuticals Limited last Annual general meeting of members was held on 25 Sep 2024 as per latest MCA records.

  • Charges

    A charge with Others amounted to Rs. 6.35 Cr with Charge ID 100983429 was registered on 11 Sep 2024.

  • Director Appointment

    Ashok Barathi Mohanachandran was appointed as a Company Secretary was appointed as a Company Secretary on 27 Jun 2024 & has been associated with this company since 8 months 6 days .

  • Balance Sheet

    Bafna Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai.

  • Charges

    A charge with Others amounted to Rs. 12.00 Cr with Charge ID 100870424 was registered on 21 Feb 2024.

Frequently asked questions

  • What is the Incorporation or founding date of Bafna Pharmaceuticals Limited?

    Bafna Pharmaceuticals Limited was incorporated on 28 Mar 1995.

  • What is authorized share capital and paid-up capital of Bafna Pharmaceuticals Limited?

    The authorized share capital of Bafna Pharmaceuticals Limited is ₹ 40.00 Cr and paid-up capital is ₹ 23.66 Cr.

  • Who are the current board members & directors of Bafna Pharmaceuticals Limited?

    Currently 11 directors are associated with Bafna Pharmaceuticals Limited.

    • Krishna Yeachuri
    • Shanmugam Hemalatha
    • Sundaresan Krishnan Palamadai
    • Akila Chandrashekar Raju
    • Vinayak Dinesh Dendukuri
    • Ravichandran Chitra
    • Upendar Mekala Reddy
    • Mahaveer Chand Bafna
    • Ashok Barathi Mohanachandran
    • Bafna Mahaveer Chand
    • Melagiri Sridhar

  • What is the registered address of Bafna Pharmaceuticals Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Bafna Pharmaceuticals Limited is 299, Thambu Chetty Street Madras India, Madras 600 001, Tamil Nadu, 600001.

  • What is the corporate identification number (CIN) and company number of Bafna Pharmaceuticals Limited?

    The corporate identification number (CIN) of Bafna Pharmaceuticals Limited is L24294TN1995PLC030698 and the company number is 030698 as per Ministry of Corporate Affairs (MCA).

  • Is Bafna Pharmaceuticals Limited registered with any stock exchange in India?

    Yes, Bafna Pharmaceuticals Limited is registered on Bombay Stock Exchange (BSE) and National Stock Exchange (NSE): BAFNAPH.

  • What is the official website of Bafna Pharmaceuticals Limited?

    The Official website of Bafna Pharmaceuticals Limited is https://www.bafnapharma.com

  • What has been the recent revenue trend for Bafna Pharmaceuticals Limited?

    According to the financial reports for the fiscal year 2024, the revenue trend for Bafna Pharmaceuticals Limited has risen by 31.50%.

  • How many employees does Bafna Pharmaceuticals Limited currently have?

    As Per 2024 financial reports, 379 employees are currently employed by Bafna Pharmaceuticals Limited.

  • What change has been observed in the net worth of Bafna Pharmaceuticals Limited, and by what percentage?

    The financial reports for the fiscal year 2024 indicates that The net worth of Bafna Pharmaceuticals Limited has experienced an upsurge of 10.05%.

  • What are the total open charges for Bafna Pharmaceuticals Limited?

    As per the financial statements for fiscal Year 2024, The total open charges for Bafna Pharmaceuticals Limited amount to ₹ 62.35 Cr.

  • When was the last Balance Sheet of Bafna Pharmaceuticals Limited filed with the ROC?

    The most recent Balance Sheet for Bafna Pharmaceuticals Limited was filed with the ROC on 31 Mar 2024.

People also Viewed

Similar Companies Based on Drug Formulation & Development